Loading...
Immunotherapies & Innovations for Infectious Diseases Congress 2022

November 23-24 2022 ENS Lyon, France

News Twitter

Program

Day 1

Wednesday, 23th November 2022

8h00

Registration & welcome coffee

8h45

Welcome Address

9h00

Opening lectures

Oxford University Tim Walsh

Tim Walsh
Professor of Medical Microbiology
Oxford University - UK

10h00

Coffee Break - Exhibition Hall - B2B Meetings

10h30

Track 1 : Alternative to antibiotics and current antivirals

Session 1

TechnoPhage Sofia Côrte Real

Sofia Côrte Real
Scientific advisor
TechnoPhage - Portugal

ORIGIMM Biotechnology Sanja Selak

Sanja Selak
Managing director and CSO
ORIGIMM Biotechnology - Austria

INSERM Vincent Libis

Vincent Libis
Research Group Leader
INSERM - France

Track 2 : New avancements in Immunotherapies

Session 1

APHP Jean Chastre

Jean Chastre
PU-PH
APHP - France

Evotec Antoine Alam

Antoine Alam
Antiviral Research Head
Evotec, France

Sanofi Kocfa Chung

Kocfa Chung
Global Medical Expert, Strategy Lead RSV Global Medical Franchise
Sanofi, France

12h00

Lunch - Exhibition Hall - B2B Meetings 2 slots

13h00

Poster Presentation - Exhibition Hall - B2B Meetings 3 slots

14h00

Track 3: Fostering infectious diseases public-private initiatives

Session 1

ANRS Hervé Raoul

Hervé Raoul
Directeur adjoint
ANRS - France

14h30

Track 1 : Alternative to antibiotics and current antivirals

Session 2

Oppilotech Ajay Mistry

Ajay Mistry
CEO
Oppilotech - UK

Stokes Laboratory Jon Stokes

Jon Stokes
Assistant Professor
Stokes Laboratory / McMaster University - Canada

Track 2 : New avancements in Immunotherapies

Session 2

Hospices Civils de Lyon Anne-Claire Lukaszewicz

Anne-Claire Lukaszewicz
Head of Department
Hospices Civils de Lyon - France

Aridis Pharmaceuticals Hasan Jafri

Hasan Jafri
Chief Medical Officer
Aridis Pharmaceuticals - USA

15h30

Coffe Break - Exhibition Hall - B2B Meetings 3 slots

16h00

Track 1 : Alternative to antibiotics and current antivirals

Session 3

Vésale Bioscience Bob Blasdel

Bob Blasdel
Research Director
Vésale Bioscience – Belgique

Deinove Alexis Rideau

Alexis Rideau
CEO
Deinove, France

Evotec
Sino
Promega

Breakthrough innovation Session

Call for Abstract Deadline: September 16th 2022

17h30

End of Day 1

19h30

Cocktail Diner at Musée des Confluences (booking mandatory)

Day 2

Thursday, 24th November 2022

8h30

Welcome coffee

9h00

Opening lectures

BioNTech Robbert Van Der Most

Robbert Van Der Most
Vice President Translational Science
BioNTech, Belgium

10h00

Coffe Break - Exhibition Hall - B2B Meetings

10h30

Track 4 : Innovative vaccines

Session 1

Inserm Anne-Sophie Beignon

Anne-Sophie Beignon
Researcher
Inserm, CEA, IMVA-HB/IDMIT - France

LoValTech Isabelle Dimier-Poisson

Isabelle Dimier-Poisson
CSO
LoValTech - France

LoValTech Patrick Barillot

Patrick Barillot
CEO
LoValTech - France

Croda

Track 5 : Diagnostic, prognostic and clinical biomarkers

Session 1

12h30

Lunch - Exhibition Hall - B2B Meetings 2 slots

14h30

Poster Presentation - Exhibition Hall - B2B Meetings 3 slots

14h30

Track 3: Fostering infectious diseases public-private initiatives

Session 2

bioMérieux François Lacoste

François Lacoste
Executive Vice President, Research & Development
bioMérieux, France
Comité stratégique de filière (CSF) Antibiorésistance - France

National Acceleration Strategy Emerging Infectious Diseases and CBRN Threats Nadia Khelef

Nadia Khelef
Coordinator
National Acceleration Strategy Emerging Infectious Diseases and CBRN Threats - France

15h15

Track 4 : Innovative vaccines

Session 2

Pasteur Institute Sylvain Baize

Sylvain Baize
PI
Pasteur Institute - France

16h15

Closing lecture

16h45

Best Poster - Annoucemment of next year edition

17h00

End of congress

ORGANIZERS